<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epstein-Barr virus (EBV) latently infects and immortalizes B lymphocytes and causes lymphoproliferative <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>We show here that the EBV nuclear antigen EBNA2 induces expression of the 2 chains of the interleukin-18 receptor (IL-18R) in Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) cell lines and in nontransformed B cells </plain></SENT>
<SENT sid="2" pm="."><plain>Activation of IL-18R expression by EBNA2 is independent of its interaction with the transcriptional repressor RBPJ kappa </plain></SENT>
<SENT sid="3" pm="."><plain>It occurs in the absence of any other <z:mp ids='MP_0001799'>viral</z:mp> protein but requires de novo synthesis of cellular proteins </plain></SENT>
<SENT sid="4" pm="."><plain>IL-18R induction is a highly specific function of EBNA2, because neither other EBV latent proteins nor the cellular proteins c-myc or Notch can exert this effect </plain></SENT>
<SENT sid="5" pm="."><plain>Using cDNA microarray expression profiling, we find that the IL-18 receptor expressed in EBV-infected <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells has signaling capacity, because IL-18 significantly modified gene expression </plain></SENT>
<SENT sid="6" pm="."><plain>We report that EBNA2 expression is associated with IL-18R expression in vivo in EBV-positive B-<z:hpo ids='HP_0002665'>lymphomas</z:hpo> from <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e> patients </plain></SENT>
</text></document>